OS Therapies Inc (OSTX)

Currency in USD
1.61
-0.09(-5.29%)
Closed·
1.64+0.03(+1.86%)
·
Earnings results expected in 13 days
OSTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.601.75
52 wk Range
1.152.57
Key Statistics
Prev. Close
1.7
Open
1.69
Day's Range
1.6-1.75
52 wk Range
1.15-2.57
Volume
555.67K
Average Volume (3m)
627.46K
1-Year Change
-19.7044%
Book Value / Share
-0.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OSTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.89
Upside
+576.27%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

OS Therapies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.89
(+576.27% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy14.00+769.57%17.00MaintainApr 01, 2026
D. Boral Capital
Buy20.00+1,142.24%-New CoverageFeb 05, 2026
Lake Street Capital Markets
Buy17.00+955.90%18.00MaintainNov 18, 2025

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.37 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OSTX Income Statement

Compare OSTX to Peers and Sector

Metrics to compare
OSTX
Peers
Sector
Relationship
P/E Ratio
−2.4x16.6x−0.5x
PEG Ratio
−0.10−0.630.00
Price/Book
−11.1x5.1x2.6x
Price / LTM Sales
-4.8x3.2x
Upside (Analyst Target)
393.8%46.3%48.8%
Fair Value Upside
Unlock25.7%6.9%Unlock

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
888.60K2.11%1.51M
Other Institutional Investors
3.98M9.46%6.76M
Public Companies & Retail Investors
37.17M88.42%63.19M
Total
42.04M100.00%71.47M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Index Funds - Vanguard Extended Market ETF0.60%253,685431
Vanguard Index Funds - Vanguard Total Stock Market ETF0.35%149,115253

People Also Watch

0.36
AGRZ
-8.62%
0.52
AIM
0.00%
0.63
SNAL
-3.26%
1.44
BIYA
-27.27%
5.370
CING
+4.27%

FAQ

What Is the OS Therapies (OSTX) Stock Price Today?

The OS Therapies stock price today is 1.61 USD.

What Stock Exchange Does OS Therapies Trade On?

OS Therapies is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for OS Therapies?

The stock symbol for OS Therapies is "OSTX."

What Is the OS Therapies Market Cap?

As of today, OS Therapies market cap is 71.47M USD.

What Is OS Therapies's Earnings Per Share (TTM)?

The OS Therapies EPS (TTM) is -0.98.

When Is the Next OS Therapies Earnings Date?

OS Therapies will release its next earnings report on May 15, 2026.

From a Technical Analysis Perspective, Is OSTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has OS Therapies Stock Split?

OS Therapies has split 0 times.

How Many Employees Does OS Therapies Have?

OS Therapies has 5 employees.

What is the current trading status of OS Therapies (OSTX)?

As of May 02, 2026, OS Therapies (OSTX) is trading at a price of 1.61 USD, with a previous close of 1.70 USD. The stock has fluctuated within a day range of 1.60 USD to 1.75 USD, while its 52-week range spans from 1.15 USD to 2.57 USD.

What Is OS Therapies (OSTX) Price Target According to Analysts?

The average 12-month price target for OS Therapies is 10.89 USD, with a high estimate of 20 USD and a low estimate of 6 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +576.27% Upside potential.

What Is the OSTX Premarket Price?

OSTX's last pre-market stock price is 1.75 USD. The pre-market share volume is 11,260.00, and the stock has decreased by 0.05, or 2.94%.

What Is the OSTX After Hours Price?

OSTX's last after hours stock price is 1.64 USD, the stock has decreased by 0.03, or 1.86%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.